Regeneron and Sanofi’s Dupixent Shows Strong Efficacy in Atopic Dermatitis Patients With Skin of Color

Atopic dermatitis is a chronic disease that disproportionately impacts communities of color Dupixent achieved 75% or greater improvement in overall dise...

June 09, 2025 | Monday | News
ByteBrain Launches MEDRAIL to Transform Clinical Trials with AI-Powered Compliance and Safety Automation

ByteBrain LLC, an emerging AI research and consulting firm, has announced the launch of MEDRAIL, an intelligent platform designed to help pharmaceutical co...

June 06, 2025 | Friday | News
Forging the Future of Biomanufacturing: How VVMF and Cytiva Are Elevating Australia’s Global Role

As the world recalibrates its life sciences infrastructure post-pandemic, Australia is stepping up as a regional powerhouse in biomanufacturing—espec...

June 05, 2025 | Thursday | Interaction
CERo Therapeutics Expands Global Patent Portfolio With New U.S. and European Grants Covering Lead Candidate CER-1236

CERo Therapeutics Holdings, Inc,an innovative immunotherapy company seeking to advance the next generation of  engineered T cell therapeutics that d...

June 03, 2025 | Tuesday | News
Danaher and AstraZeneca Partner to Advance AI-Powered Diagnostics for Precision Medicine

Danaher has entered a partnership with AstraZeneca to scale precision medicine, including developing the next generation of AI-powe...

May 30, 2025 | Friday | News
Astellas Inks $1.54 Billion Licensing Deal with Evopoint for ADC Candidate XNW27011 Targeting CLDN18.2

- Agreement grants Astellas exclusive worldwide rights (excluding China's mainland, Hong Kong, Macao and Taiwan region) to develop and commercialize XNW2...

May 30, 2025 | Friday | News
Beghou Consulting Expands Leadership Team with Appointment of Robert Rouse and Jason Stephani as Partners

These latest partner additions extend Beghou’s proven track record in adding top talent and investing in new technology to remain agile and respons...

May 30, 2025 | Friday | News
Alvotech and Advanz Pharma Expand Biosimilars Partnership with Three New Candidates in Europe

Alvotech , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a U...

May 29, 2025 | Thursday | News
Ecolab’s Strategic Move in Pennsylvania: A Catalyst for Biotherapeutic Innovation

  In this exclusive interview with BioPharma BoardRoom, Jessay Devassy, Manager, Bioprocess Applications at Ecolab Bioprocessing&...

May 23, 2025 | Friday | Interaction
MedX Health Expands Teledermatology Footprint in Italy Through Strategic Partnership with Vitamed and Medispa

MedX Health Corp. , a global leader in teledermatology, is pleased to announce a strategic collaboration in the Italian healthcare market between Vitamed...

May 22, 2025 | Thursday | News
Microba’s MetaXplore™ GI Plus Demonstrates Clinical Impact in Over 70% of Patients With Chronic Gut Symptoms

Microba Life Sciences Limited, a precision microbiome company,  announces preliminary results from the analysis of over 4,600 MetaXplore™ GI P...

May 16, 2025 | Friday | News
Merck CEO Belén Garijo Steers Strong Q1 as Process Solutions Powers Growth and Strategic Vision

Net sales increased organically by 2.5% to € 5.3 billion EBITDA pre up organically by 5.8% to € 1.5 billion All three b...

May 15, 2025 | Thursday | Company results
Illumina Unveils DRAGEN™ v4.4 with Breakthrough Accuracy and Oncology-Ready Applications

Building on reputation for unparalleled performance, latest software delivers even greater accuracy, with 30% improvement in structural variant calling ...

May 14, 2025 | Wednesday | News
Exelixis Advances Invenra-Discovered XB628 into Phase 1 Clinical Trial for Solid Tumors

Invenra Inc., a biotechnology company specializing in the discovery and development of multispecific antibodies,  announced that its collaboration par...

May 14, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close